The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Regushevskaia D.V.

Pervyĭ MGMU im. I.M. Sechenova

Novikova N.A.

Pervyĭ MGMU im. I.M. Sechenova, klinika kardiologii

Sedov V.P.

Pervyĭ MGMU im. I.M. Sechenova

Gilyarov M.Yu.

I.M. Sechenov First Moscow State Medical University under the Ministry of Health of the Russia, 119991, Moscow, Russia;
N.I. Pirogov Moscow Municipal Hospital №1, Moscow, 119049, Russia

Keĭko O.I.

Pervyĭ MGMU im. I.M. Sechenova

Petrova G.A.

Nizhni Novgorod State Medical Academy, Nizhni Novgorod, Russia

Surikova M.A.

A.K. Eramishantsev Municipal Clinical Hospital, Moscow, Russia

Egorova T.D.

Pervyĭ MGMU im. I.M. Sechenova

Efficacy and safety of short regimen of anticoagulant therapy in patients with atrial fibrillation and low risk of thromboembolic complications

Authors:

Regushevskaia D.V., Novikova N.A., Sedov V.P., Gilyarov M.Yu., Keĭko O.I., Petrova G.A., Surikova M.A., Egorova T.D.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(4): 68‑78

Read: 1493 times

Contact the author
Table of contents

EFFICACY AND SAFETY OF SHORT REGIMEN OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND LOW RISK OF THROMBOEMBOLIC COMPLICATIONS
EFFICACY AND SAFETY OF SHORT REGIMEN OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND LOW RISK OF THROMBOEMBOLIC COMPLICATIONS

To cite this article:

Regushevskaia DV, Novikova NA, Sedov VP, et al. Efficacy and safety of short regimen of anticoagulant therapy in patients with atrial fibrillation and low risk of thromboembolic complications. Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(4):68‑78. (In Russ.)

 
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Left atrial redu­ction in mitral valve surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):460-470
Effi­cacy and Safety of the Oral Anti­coagulant DIMO­LEGIN Compared to Enoxaparin Sodium for the Prevention of Venous Thro­mboembolism Following Major Joint Replacement Surgery (hip or knee arthroplasty): A Randomized, Double-Blind, Multicenter Trial. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):577-585
Atrial fibrillation recu­rrences after catheter treatment and labo­ratory markers: is there a correlation?. Russian Journal of Preventive Medi­cine. 2025;(7):56-62
A clinical case of treating a patient with severe ischemic stroke and cancer. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):114-117
Visceral obesity is a reve­rsible factor in pathogenesis of major cardiovascular diseases. Russian Cardiology Bulletin. 2025;(3):11-16
Sagi­ttal sinus thro­mbosis during pregnancy with the deve­lopment of ischemic stroke. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):87-91
Thro­mbotic complications in pancreatitis: diagnostics and prevention. Russian Journal of Preventive Medi­cine. 2025;(10):115-122
Pote­ntial for the six-minute walk test use in patients with atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(10):129-133
Popu­lation portrait of the atrial fibrillation by the ESSE-RF study.. Russian Journal of Preventive Medi­cine. 2025;(11):7-13
Portal vein thro­mbosis: obse­rvations from the practice. Russian Bulletin of Obstetrician-Gynecologist. 2025;(6):59-63
Abstract:

86 patients with atrial fibrillation/atrial flutter and low risk of thromboembolic complications were included in prospective comparative clinical trial. Patients were divided into 2 groups. Patients from the first group received enoxaparin before and during 7-10 days after cardioversion; patients from the second group received warfarin or warfarin in combination with low molecular weight heparins before sinus rhythm restoration and warfarin during 4 weeks after rhythm restoration. It is shown that short (7-10 days) regimen of anticoagulant therapy with low molecular weight heparins in therapeutic doses in case of low thromboembolic risk allows achieving effective and safe thromboprophylaxis after cardioversion just like with standard warfarin therapy.

Keywords:

atrial fibrillation
cardioversion
thromboembolic complications
anticoagulant therapy
low molecular weight heparins
warfarin

Authors:

Regushevskaia D.V.

Pervyĭ MGMU im. I.M. Sechenova

Novikova N.A.

Pervyĭ MGMU im. I.M. Sechenova, klinika kardiologii

Sedov V.P.

Pervyĭ MGMU im. I.M. Sechenova

Gilyarov M.Yu.

I.M. Sechenov First Moscow State Medical University under the Ministry of Health of the Russia, 119991, Moscow, Russia;
N.I. Pirogov Moscow Municipal Hospital №1, Moscow, 119049, Russia

Keĭko O.I.

Pervyĭ MGMU im. I.M. Sechenova

Petrova G.A.

Nizhni Novgorod State Medical Academy, Nizhni Novgorod, Russia

Surikova M.A.

A.K. Eramishantsev Municipal Clinical Hospital, Moscow, Russia

Egorova T.D.

Pervyĭ MGMU im. I.M. Sechenova

Close metadata

References:

  1. Metodiki klinicheskikh laboratornykh issledovanii. Spravochnoe posobie. T. 1. Gematologicheskie issledovaniya. Koagulogicheskie issledovaniya. Khimiko-mikroskopicheskie issledovaniya. Pod red. V.V. Men'shikova. M: Labora 2008; 448.
  2. Zateishchikov D.A., Zotova I.V., Dankovtseva E.N. i dr. Klinicheskie i geneticheskie aspekty mertsatel'noi aritmii: sovremennoe sostoyanie problemy. Kremlevskaya meditsina. Klin vestn 2010; 2: 6-10.
  3. Zotova I.V., Zateishchikov D.A., Sidorenko B.A. Vyyavlenie i morfofunktsional'nye prediktory tromboza v ushke levogo predserdiya u bol'nykh s mertsatel'noi aritmiei. Kardiologiya 2004; 6: 65-74.
  4. Zotova I.V., Isaeva M.Yu., Vanieva O.S. i dr. Sistema gemostaza u bol'nykh s mertsatel'noi aritmiei: markery tromboza ushka levogo predserdiya. Kardiologiya 2008; 2: 36-40.
  5. Ikorkin M.R., Zharinov O.I., Levchuk N.P. i dr. Markery riska tromboembolicheskikh oslozhnenii u patsientov s persistiruyushchei fibrillyatsiei predserdii. Ukr kardiol zhurn 2009; 6: 32-40.
  6. Nazarenko G.I., Bychkova O.P., Zamiro T.N. i dr. Vozmozh­­-nosti diagnostiki tromboza ushka levogo predserdiya u bol'nykh s fibrillyatsiei predserdii: transezofageal'-naya ekhokardiografiya i mnogosrezovaya spiral'naya komp'yuternaya tomografiya serdtsa. Ros med vesti 2005; 10: 30-34.
  7. Papayan L.P., Knyazeva E.S. D-dimer v klinicheskoi praktike. Posobie dlya vrachei. Pod red. N.N. Petrishcheva. M: Insait poligrafik 2002; 20.
  8. Serdechnaya E.V., Tatarskii B.A., Kul'minskaya L.A. Dopolnitel'nye markery riska tromboembolicheskogo insul'ta u bol'nykh s fibrillyatsiei predserdii. Ekologiya cheloveka 2006; 9: 37-42.
  9. Alessandri N., Mariani S., Ciccaglioni A. et al. Thrombus formation in the left atrial appendage in the course of atrial fibrillation. Eur Rev Med Pharmacol Sci 2003; 7: 65-73.
  10. Antonielli E., Pizzuti A., Palinkas A. et al. Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 2002; 39: 1443-1449.
  11. Bellotti R., Spirito R., Lupi G. et al. Left Atrial Appendage Function Assessed by Transesophageal Echocardiography Before and on the Day After Elective Cardioversion for Nonvalvular Atrial Fibrillation. Am J Cardiol 1998; 81: 1199-1202.
  12. Black I.W., Fatkin D., Sagar K.B. et al. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study. Circulation 1994; 89: 2509-2513.
  13. Colonna R., Kosmala W., Sorino M. et al. New transthoracic echocardiographic M-mode sign to detect post-cardioversion atrio auricular dysfunction: correlations with transesophageal echocardiography. ESC 2010 ; Abstract P4249: http:spo.escardio.org/AbstractDetails.aspx?id=92543&eevtid=40.
  14. De Luca I., Sorino M., Del Salvatore B. et al. A new therapeutic strategy for electrical cardioversion of atrial fibrillation. Ital Heart J 2001; 2: 835-840.
  15. De Luca I., Sorino M., De Luca L. et al. Pre- and post-cardioversion transesophageal echocardiography for brief anticoagulation therapy with enoxaparin in atrial fibrillation patients: a prospective study with a 1-year follow-up. Int J Cardiol 2005; 102: 447-454.
  16. Fatkin D., Kelly R., Feneley M. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23: 961-969.
  17. Fukuda S., Shimada K., Kawasaki T. et al. Transnasal transesophageal echocardiography in the detection of left atrial thrombus. J Cardiol 2009; 54: 425-431.
  18. Garcia-Fernandez M.A., Torrecilla E.G., Roman D.S. et al. Left atrial appendage doppler flow patterns: Implications on thrombus formation. Am Heart J 1992; 124: 955-961.
  19. Habara S., Dote K., Kato M. et al. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 2007; 28: 2217-2222.
  20. Hirai T., Sakurai K., Tani M. et al. Elevated Levels of Fibrin Monomer as a Predictor of Thromboembolism in Patients with Atrial Fibrillation. Circulation 2003; 67: 507.
  21. Hundley W.G., Bluemke D.A., Finn J. et al. ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 2010; 55: 2614-2662.
  22. Inoue H., Nozawa T., Okumura K. et al. Prothrombotic Activity Is Increased in Patients With Nonvalvular Atrial Fibrillation and Risk Factors for Embolism. Chest 2004; 126: 687-692.
  23. Ito T., Suwa M., Otake Y. et al. Assessment of left atrial appendage function after cardioversion of atrial fibrillation: Relation to left atrial mechanical function. Am Heart J 1998; 135: 1020-1026.
  24. Jadidi A.S., Lederlin M., Montaudon M. et al. Non-invasive Evaluation Of Left Atrial Appendage (LAA) Mechanical Function and Risk of LAA Thrombogenesis in patients with Atrial Fibrillation (AF) using MRI vs TOE. Poster Session ESC 2010 Abstract P872: http:spo.escardio.org/AbstractDetails.aspx?id=90243&eevtid=40.
  25. Kamp O., Verhorst M.J., Welling R.C. et al. Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation. Eur Heart J 1999; 20: 979-985.
  26. Khan I.A. Atrial stunning: basics and clinical considerations. Int J Cardiol 2003; 92: 113-128.
  27. Klein A.L., Jasper S.E., Katz W.E. et al. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: Assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study. Eur Heart J 2006; 27: 2858-2865.
  28. Kouris N., Goranitou G., Grasses H. et al. 1000 Simple Doppler echocardiographic parameters in predicting recurrence of atrial fibrillation after successful cardioversion. Eur J Echocardiogr 2005; 6: S160-S160.
  29. Li Y.H., Lai L., Shyu K.G. et al. Clinical implications of left atrial appendage flow patterns in nonrheumatic atrial fibrillation. Chest 1994; 105: 748-752.
  30. Mahe I., Drouet L., Simoneau G. et al. D-dimer can predict survival in patients with chronic atrial fibrillation. Blood Coagul Fibrinolys 2004; 15: 413-417.
  31. Manning W.J., Leeman D.E., Gotch J. et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Col Cardiol 1989; 13: 617-623.
  32. Manning W.J., Silverman D.I., Katz S.E. et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23: 1535-1540.
  33. Mattioli A.V., Sansoni S., Lucchi G.R. et al. Serial evaluation of left atrial dimension after cardioversion for atrial fibrillation and relation to atrial function. Am J Cardiol 2000; 85: 832-836.
  34. Melduni R.M., Chandrasekaran K., Friedman A. et al. Does Left Atrial Appendage Peak Emptying Flow Velocity Predict the Electrical Energy Required to Achieve Successful Direct-current Cardioversion in Patients with Persistent Atrial Fibrillation? J Am Soc Echocardiogr 2007; 20: Issue 8: 1004-1008.
  35. Mitusch R., Siemens H., Garbe M. et al. Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thromb Haemost 1996; 75: 219-223.
  36. Mohrs O.K., Nowak B., Petersen S.E. et al. Thrombus Detection in the Left Atrial Appendage Using Contrast-Enhanced MRI: A Pilot Study. Am J Roentgenol 2006; 186: 198-205.
  37. Muellerleile K., Sultan A., Groth M. et al. Left atrial appendage flow velocities: assessment by velocity encoded magnetic resonance imaging. J Cardiovasc Magnetic Reson 2011; 13: 252.
  38. Mugge A., Kuhn H., Nikutta et al. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolic risk. J Am Coll Cardiol 1994; 23: 599-607.
  39. Narumiya T., Sakamaki T., Sato Y. et al. Relationship Between Left Atrial Appendage Function and Left Atrial Thrombus in Patients With Nonvalvular Chronic Atrial Fibrillation and Atrial Flutter. Circulation 2003; 67: 68-72.
  40. Nozawa T., Inoue H., Hirai T. et al. D-dimer level influences thromboembolic events in patients with atrial fibrillation. Int J Cardiol 2006; 109: 59-65.
  41. Ohyama H., Hosomi N., Takahashi T. et al. Comparison of Magnetic Resonance Imaging and Transesophageal Echocardiography in Detection of Thrombus in the Left Atrial Appendage. Stroke 2003; 34: 2436-2439.
  42. Okuyama H., Hirono O., Liu L. et al. Higher Levels of Serum Fibrin-Monomer Reflect Hypercoagulable State and Thrombus Formation in the Left Atrial Appendage in Patients With Acute Ischemic Stroke. Circulation 2006; 70: 971-976.
  43. Omran H., Jung W., Rabahieh R. et al. Left Atrial Chamber and Appendage Function After Internal Atrial Defibrillation: A Prospective and Serial Transesophageal Echocardiographic Study. J Am Coll Cardiol 1997; 29: 131-138.
  44. Pozzoli M., Selva A., Skouse D. et al. Visualization of Left Atrial Appendage and Assessment of its Function by Transthoracic Second Harmonic Imaging and Contrast-Enhanced Pulsed Doppler European. J Echocardiogr 2002; 3: 13-23.
  45. Somlói M., Tomcsányi J., Nagy E. et al. D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation. Am J Cardiol 2003; 92: 85-87.
  46. Sorino M., Colonna R., De Luca L. et al. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study). J Cardiovascular Med 2007; 8: 1034-1042.
  47. Tabata M.D., Oki M.D., Iuchi M.D. et al. Evaluation of Left Atrial Appendage Function by Measurement of Changes in Flow Velocity Patterns After Electrical Cardioversion in Patients With Isolated Atrial Fibrillation. J Am Coll Cardiol 1997; 79: 615-620.
  48. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography Transesophageal Echocardiographic Correlates of Thromboembolism in High-Risk Patients with Nonvalvular Atrial Fibrillation. Ann Intern Med 1998; 128: 639-647.
  49. Tieleman R.G., Van Gelder I.C., Crijns H.J. et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998; 31: 167-173.
  50. Vene N., Mavri A., Stegnar M. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy. Thromb Haemost 2003; 90: 1163-1172.
  51. Verhorst M.J., Kamp O., Visser C.A. et al. Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and systemic embolism. J Am Coll Cardiol 1993; 71: 192-196.
  52. Verhorst M.J., Kamp O., Welling R.C. et al. Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion off atrial fibrillation. J Am Coll Cardiol 1997; 79: 1355-1359.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.